Olympian Clinical Research
DECEMBER 19, 2023
With ongoing research and clinical trials , institutions like Olympian Clinical Research are at the forefront of finding innovative treatment options. Family History: Genetics plays a significant role. The post Quick Guide to Pediatric Plaque Psoriasis appeared first on Olympian Clinical Research.
Olympian Clinical Research
NOVEMBER 6, 2023
While the exact cause is unknown, factors like genetics, inflammation, and hormones play a role. Here are some common triggers of HS: Hormonal Changes: Many individuals with HS report flare-ups during periods of hormonal change, such as menstruation, pregnancy, or menopause.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Olympian Clinical Research
MARCH 3, 2023
In contrast, pediatric eczema is typically associated with genetics and family history. When we are under stress, our bodies release cortisol, a hormone that can weaken the skin’s natural barrier and make it more susceptible to irritation and inflammation. Stress Stress is a known trigger for adult eczema outbreaks.
Trialfacts
NOVEMBER 23, 2022
Achondroplasia (ACH) is a genetic condition that affects children’s growth. CNP is a hormone produced by the body that plays an important role in the bone growth of children. About the Research Center: Parexel. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process.
The Pharma Data
AUGUST 15, 2021
Advise patients of these risks and the need for effective non-hormonal contraception. WELIREG can render some hormonal contraceptives ineffective. This is a rare genetic disease with an estimated incidence of 10,000 people in the U.S. WELIREG can render some hormonal contraceptives ineffective. Lactation.
XTalks
SEPTEMBER 17, 2020
While clinical researchers occasionally need to identify and validate a new surrogate endpoint for a given trial, choosing endpoints that have been previously used as the basis of NDAs and BLAs can clear the path to eventual approval. The tumor secretes adrenocorticotropic hormone (ACTH), which stimulates cortisol production.
The Pharma Data
JUNE 24, 2021
The prognosis for men with advanced prostate cancer has significantly improved since the introduction of novel hormone therapies, but additional therapeutic options are needed for the approximately 25 percent of men with tumors harboring DNA damage response (DDR) gene mutations, who may have poorer outcomes,” said Chris Boshoff, M.D.,
Expert insights. Personalized for you.
52 
Let's personalize your content